Evidence map›Paper›PMID 38239322›Full record

ArticleFrontiers in neurology2023

Assessing risk factors associated with breakthrough early post-traumatic seizures in patients receiving phenytoin prophylaxis.

Eugene Generoso, Calvin Diep, Carolyn Hua, Elizabeth Rader, Ran Ran, Nathanael J Lee, Lucia Rivera-Lara

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eugene Generoso *Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United States.
Calvin Diep *Department of Pharmacy, Stanford Health Care, Palo Alto, CA, United States.
Carolyn HuaDepartment of Pharmacy, Stanford Health Care, Palo Alto, CA, United States.
Elizabeth RaderDepartment of Pharmacy, Stanford Health Care, Palo Alto, CA, United States.
Ran RanDepartment of Emergency and Critical Care Medicine, Oregon Health & Science University, Portland, OR, United States.
Nathanael J LeeDepartment of Neurology, Stanford Health Care, Palo Alto, CA, United States.
Lucia Rivera-LaraDepartment of Neurology, Stanford Health Care, Palo Alto, CA, United States.
Stanford Health Care · USOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Post-traumatic seizure (PTS) is a well-known complication of traumatic brain injury (TBI). The objective of this study was to identify risk factors associated with breakthrough early PTS in TBI patients receiving phenytoin prophylaxis. Methods: This was a single-centered retrospective study including adult patients admitted to the intensive care unit (ICU), had a TBI, and started on phenytoin for seizure prophylaxis within 24 h of admission. The primary outcome was the incidence and factors associated with early PTS, defined as a confirmed seizure on a continuous electroencephalogram within 7 days of TBI. Secondary outcomes included the association between early post-traumatic seizures and ICU length of stay, hospital length of stay, and in-hospital mortality. Results: A total of 105 patients were included in the final analysis. Patients with early PTS were older (65 vs. 48 years old, Conclusion: Patients with higher age, Marshall score, and neurosurgical procedures for hematoma evacuation had higher incidences of breakthrough early PTS despite the use of phenytoin prophylaxis. The majority of patients with early PTS had therapeutic phenytoin levels at the time of seizure when a level was available; however, approximately half (43%) did not have a level.

Indexed as

phenytoinpost-traumatic epilepsyrisk factorsseizure prophylaxistraumatic brain injury

Identifiers

PMID38239322
PMCPMC10795534
OpenAlexW4390588602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.